| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/12/2007 | US20070082359 Identifying a compound that inhibits assembly of a viral capsid by performing assembly reaction using capsid polypeptides labeled with a fluorescent dye that changes fluorescence at high concentration, resulting in juxtaposition of at least one of the N-terminus and C-terminus where the dye is attached |
| 04/12/2007 | US20070082345 Secretory protein or membrane protein |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082333 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 04/12/2007 | US20070082056 Antibiotic peptide product |
| 04/12/2007 | US20070082002 Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof |
| 04/12/2007 | US20070081995 Methods and compositions for targeting IFNAR2 |
| 04/12/2007 | US20070081994 Chimeric Heteromultimer Adhesins |
| 04/12/2007 | US20070081990 Regulation of expression of high-affinity immunoglobulin e (ige) receptor beta-chain |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | DE112005000737T5 Mit Heparansulfat-Zuckerketten modifizierte Heparin-bindende Proteine, Verfahren zur Erzeugung derselben und Arzneimittel, welche dieselben enthalten With heparan sulfate sugar chains modified heparin-binding proteins, methods for producing the same and pharmaceutical compositions containing the same |
| 04/12/2007 | CA2625183A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | CA2624379A1 Nucleic acids encoding a functional mammalian purinoreceptor, p2x3, methods of production and use thereof |
| 04/12/2007 | CA2624087A1 Regulation of tool-like receptors on stem cells |
| 04/12/2007 | CA2605781A1 Antigen binding molecules having modified fc regions and altered binding to fc receptors |
| 04/11/2007 | EP1772519A1 RNA binding protein and binding site useful for expression of recombinant molecules |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772515A1 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/11/2007 | EP1771554A2 Microbially expressed xylanases and their use as feed additives and other uses |
| 04/11/2007 | EP1771205A2 Novel antigen-binding polypeptides and their uses |
| 04/11/2007 | EP1771198A2 Interferon-alpha polypeptides and conjugates |
| 04/11/2007 | EP1730313A4 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 04/11/2007 | EP1543106B1 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 04/11/2007 | EP1175227B1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 04/11/2007 | EP1100825B1 Human mink gene mutations associated with arrhythmia |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP0961780B1 Protein markers for lung cancer and use thereof |
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | EP0692031B1 Heterologous antigens in live cell vaccine strains |
| 04/11/2007 | CN1946847A Process for producing dipeptide |
| 04/11/2007 | CN1946738A Animal product free system and process for purifying a botulinum toxin |
| 04/11/2007 | CN1944663A Method for preparing avenin ACE inhibiting peptide |
| 04/11/2007 | CN1944662A Preparing and application method for foam active protein of beer |
| 04/11/2007 | CN1309833C Angiostatin and its use for preparing medicament |
| 04/11/2007 | CN1309832C Sodium/protein countertransporter gene |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309825C Method for production of recombinant proteins in eukaryote cells |
| 04/11/2007 | CN1309824C Antibiotic peptide gene converted viscons bacillus engineering bacterium and its preparing method and use |
| 04/11/2007 | CN1309737C Recombinant gelatins |
| 04/11/2007 | CN1309735C Soluble CTL A4 mutant molecules and use thereof |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309733C Pepties from the 16/6id antibody for treating SLE |
| 04/10/2007 | US7202356 Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast |
| 04/10/2007 | US7202354 Hepatitis B virus surface antigen mutant and methods of detection thereof |
| 04/10/2007 | US7202345 PRO 1384 antibodies |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202333 Recombinant soluble fragment of the alpha-subunit polypeptide of human mast cell IgE surface receptor, capable of binding to human IgE; can be used in diagnostic, drug screening and antiallergen applications |
| 04/10/2007 | US7202210 Premature peptide for use in treatment of nervous system, muscular, heart, diabetic and bone disorders |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202080 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 04/10/2007 | US7202079 Evpression vector for use as tool in genetic engineering |
| 04/10/2007 | US7202077 Comprises nucleotide sequences for use as gene transfer tools; plasmids; expression vectors |
| 04/10/2007 | US7202072 Genetically engineered eukaryotic hydrolase expressed in methylotrophic yeast for identifying modulators of tumor activities |
| 04/10/2007 | US7202069 novel enzymes that can reduce 4-haloacetoacetic acid esters using NADH as a coenzyme and produce (S)-4-halo-3-hydroxybutyric acid esters having high optical purities |
| 04/10/2007 | US7202067 Carotene synthase gene and uses therefor |
| 04/10/2007 | US7202059 Fusion proteins capable of being secreted into a fermentation medium |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202056 Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19 |
| 04/10/2007 | US7202055 Preparing cells for use as bioreactors for expression of heterologous polypeptides |
| 04/10/2007 | US7202054 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |
| 04/10/2007 | US7202045 Detection and treatment of cancers of the lung |
| 04/10/2007 | US7202034 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/10/2007 | US7202021 Antibody for use in the detection of viral protein; for use in diagnosis of creutzfeldt-jakob disease |
| 04/10/2007 | US7201908 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/10/2007 | US7201884 Microbiological or enzymatic process for producing cellular product; process involves introducing feed stream of gas of low solubility into aqueous medium containing microorganism capable of converting gaseous feed stream to cellular product |
| 04/10/2007 | CA2354377C A method for manufacturing glycoproteins having human-type glycosylation |
| 04/10/2007 | CA2254931C Human monoclonal antibodies to the hepatitis b surface antigen |
| 04/10/2007 | CA2226880C Cyclosporin derivatives with anti-hiv effect |
| 04/10/2007 | CA2209172C Murine monoclonal anti-idiotype antibody 3h1 |
| 04/10/2007 | CA2173834C Monoclonal antibodies to thymidine kinase isozymes |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2150816C Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications |
| 04/10/2007 | CA2125174C Novel polypeptides for promoting cell attachment |
| 04/10/2007 | CA2121599C Monoclonal antibodies directed against the microtubule-associated protein tau |
| 04/10/2007 | CA2084351C P0438 - a new calcium-regulated promoter |
| 04/10/2007 | CA2071016C Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto |
| 04/10/2007 | CA2026250C Detection and quantification of neu related proteins in the biological fluids of humans |
| 04/05/2007 | WO2007038755A1 In vitro protein synthesis systems for membrane proteins that include apolipoproteins and phospholipid-apolipoprotein particles |
| 04/05/2007 | WO2007037791A2 Sustainable supply of bioactive marine products |
| 04/05/2007 | WO2007036706A1 Variants of the lantibiotic mersacidin and their use |
| 04/05/2007 | WO2007036299A2 Method for amidating polypeptides with basic aminoacid c- terminals by means of specific endoproteases |
| 04/05/2007 | WO2007015848A9 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/05/2007 | WO2004028467A3 Diagnosis of bovine viral diarrhea virus |
| 04/05/2007 | US20070079392 Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
| 04/05/2007 | US20070078260 Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them |
| 04/05/2007 | US20070078084 Compositions and methods related to production of erythropoietin |
| 04/05/2007 | US20070077640 Determining if a tumor is resistant to treatment with the tyrosine kinase inhibitor imatinib mesylate by identifying a first amino acid at a position of interest in an Abl kinase domain polypeptide and comparing it to a known specific sequence |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077626 Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same |
| 04/05/2007 | US20070077625 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 04/05/2007 | US20070077624 Recombinant production of mixtures of antibodies |
| 04/05/2007 | US20070077623 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 04/05/2007 | US20070077622 Expression vector comprising nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) proteins for enhancing production of functional heterologous polypeptides |
| 04/05/2007 | US20070077621 Production of CPD glycosylases |
| 04/05/2007 | US20070077620 Expressing nucleic acid that codes a gene with tRNASep activity and one that codes a gene with SepRS that preferentially aminoacylates tRNASep with phosphoserine; the tRNASep recognizes codons so that phosphoserine is incorporated; sequences of Archaeoglobus fulgidus, or of a methanogenic archaea |
| 04/05/2007 | US20070077619 Secretion of proteins from yeasts |
| 04/05/2007 | US20070077618 heating an aqueous solution of 1,5-D-anhydrofructose at an acidic pH, in the presence of antioxidant selected from ascorbic acid, erythorbic acid, ethylenediamine tetraacetic acid and their salts |